Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Estimation of apparent clearance of valproic acid in adult Saudi patients.

Alqahtani S, Alandas N, Alsultan A.

Int J Clin Pharm. 2019 Aug;41(4):1056-1061. doi: 10.1007/s11096-019-00864-w. Epub 2019 Jun 20.

PMID:
31222537
2.

Estimation of Phenytoin Pharmacokinetic Parameters in Saudi Epileptic Patients.

Alqahtani S, Alzaidi T, Alotaibi M, Alsultan A.

Pharmacology. 2019;104(1-2):60-66. doi: 10.1159/000500314. Epub 2019 May 8.

PMID:
31067540
3.

Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection.

Al-Shaer MH, Alghamdi WA, Alsultan A, An G, Ahmed S, Alkabab Y, Banu S, Barbakadze K, Houpt E, Kipiani M, Mikiashvili L, Cegielski JP, Kempker RR, Heysell SK, Peloquin CA.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00279-19. doi: 10.1128/AAC.00279-19. Print 2019 Jul.

4.

Angiogenesis in 90Y-Radioembolization of Colorectal Liver Metastases.

Alsultan AA, Barentsz MW, Smits MLJ, Koopman M, Lam MGEH, Rosenbaum CENM.

Semin Nucl Med. 2019 May;49(3):204-210. doi: 10.1053/j.semnuclmed.2019.01.004. Epub 2019 Jan 31. Review.

PMID:
30954186
5.

Optimizing Gentamicin Dosing in Pediatrics Using Monte Carlo Simulations.

Alsultan A, Abouelkheir M, Elsharawy Y, Alkoraishi A, Osman R, Neely MN, Mansy W, Algahtani S.

Pediatr Infect Dis J. 2019 Apr;38(4):390-395. doi: 10.1097/INF.0000000000002120.

PMID:
30882729
6.

Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.

Alghamdi WA, Alsultan A, Al-Shaer MH, An G, Ahmed S, Alkabab Y, Banu S, Barbakadze K, Houpt E, Kipiani M, Mikiashvili L, Schmidt S, Heysell SK, Kempker RR, Cegielski JP, Peloquin CA.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00055-19. doi: 10.1128/AAC.00055-19. Print 2019 May.

7.

Bacterial Factors and Relapse after Tuberculosis Therapy.

Alsultan A, Ashkin D, Peloquin CA.

N Engl J Med. 2019 Jan 10;380(2):197. doi: 10.1056/NEJMc1813645. No abstract available.

PMID:
30628424
8.

Identifying Prognostic Factors That Influence Outcome of Childhood Acute Myeloid Leukemia in First Relapse in Saudi Arabia: Results of the Multicenter SAPHOS Study.

Jastaniah W, Bayoumy M, Alsultan A, Al Daama S, Ballourah W, Al-Anzi F, Al Shareef O, Al Sudairy R, Abrar MB, Al Ghemlas I.

Clin Lymphoma Myeloma Leuk. 2018 Dec;18(12):773-780. doi: 10.1016/j.clml.2018.09.001. Epub 2018 Sep 12.

PMID:
30340992
9.

Utilizing Whole-Exome Sequencing to Characterize the Phenotypic Variability of Sickle Cell Disease.

Alsultan A, Al-Suliman AM, Aleem A, AlGahtani FH, Alfadhel M.

Genet Test Mol Biomarkers. 2018 Sep;22(9):561-567. doi: 10.1089/gtmb.2018.0058. Epub 2018 Sep 5.

PMID:
30183354
10.

Inhibition of cytochrome P450 enzymes by thymoquinone in human liver microsomes.

Albassam AA, Ahad A, Alsultan A, Al-Jenoobi FI.

Saudi Pharm J. 2018 Jul;26(5):673-677. doi: 10.1016/j.jsps.2018.02.024. Epub 2018 Feb 12.

11.

Evaluation of the Adequacy of WHO Revised Dosages of the First-Line Antituberculosis Drugs in Children with Tuberculosis Using Population Pharmacokinetic Modeling and Simulations.

Horita Y, Alsultan A, Kwara A, Antwi S, Enimil A, Ortsin A, Dompreh A, Yang H, Wiesner L, Peloquin CA.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00008-18. doi: 10.1128/AAC.00008-18. Print 2018 Sep.

12.

Prevalence of hereditary cancer susceptibility syndromes in children with cancer in a highly consanguineous population.

Jastaniah W, Aljefri A, Ayas M, Alharbi M, Alkhayat N, Al-Anzi F, Yassin F, Alkasim F, Alharbi Q, Abdullah S, Abrar MB, Alsultan A.

Cancer Epidemiol. 2018 Aug;55:88-95. doi: 10.1016/j.canep.2018.05.006. Epub 2018 May 30.

PMID:
29859499
13.

Withdrawal of two generic clopidogrel products in Saudi Arabia for non-bio-equivalence.

Alsultan AS, Hakeam HA.

Ann Saudi Med. 2018 May-Jun;38(3):233-234. doi: 10.5144/0256.4947.2018.233. No abstract available.

14.

Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens.

Alqahtani SA, Alsultan AS, Alqattan HM, Eldemerdash A, Albacker TB.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00088-18. doi: 10.1128/AAC.00088-18. Print 2018 Jul.

15.

Optimizing Amikacin Dosage in Pediatrics Based on Population Pharmacokinetic/Pharmacodynamic Modeling.

Alqahtani S, Abouelkheir M, Alsultan A, Elsharawy Y, Alkoraishi A, Osman R, Mansy W.

Paediatr Drugs. 2018 Jun;20(3):265-272. doi: 10.1007/s40272-018-0288-y.

PMID:
29569124
16.

Optimizing Vancomycin Monitoring in Pediatric Patients.

Alsultan A, Abouelkheir M, Alqahtani S, Aljabri A, Somily AM, Alsubaie S, Alrabiaah A, Bukhari E, Alzamil F.

Pediatr Infect Dis J. 2018 Sep;37(9):880-885. doi: 10.1097/INF.0000000000001943.

PMID:
29461449
17.

Secondary Hemophagocytic Syndrome Associated with COG6 Gene Defect: Report and Review.

Althonaian N, Alsultan A, Morava E, Alfadhel M.

JIMD Rep. 2018;42:105-111. doi: 10.1007/8904_2018_88. Epub 2018 Feb 15.

18.

The prevalence of cardiovascular diseases risk factors associated with psoriasis in Saudi Arabia.

Alhomoud AS, Alnemer KA, Aldokheal MI, Alsultan AM, Alzahrani ZK.

Electron Physician. 2017 Nov 25;9(11):5793-5799. doi: 10.19082/5793. eCollection 2017 Nov.

19.

Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).

Bader P, Kuçi Z, Bakhtiar S, Basu O, Bug G, Dennis M, Greil J, Barta A, Kállay KM, Lang P, Lucchini G, Pol R, Schulz A, Sykora KW, von Luettichau I, Herter-Sprie G, Uddin MA, Jenkin P, Alsultan A, Buechner J, Stein J, Kelemen A, Jarisch A, Soerensen J, Salzmann-Manrique E, Hutter M, Schäfer R, Seifried E, Klingebiel T, Bonig H, Kuçi S.

Bone Marrow Transplant. 2018 Jul;53(7):852-862. doi: 10.1038/s41409-018-0102-z. Epub 2018 Jan 29.

20.

Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.

Alqahtani SA, Alsultan AS, Alqattan HM, Eldemerdash A, Albacker TB.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02241-17. doi: 10.1128/AAC.02241-17. Print 2018 Apr.

21.

Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis.

Alsultan A, Basher E, Alqanatish J, Mohammed R, Alfadhel M.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26912. Epub 2017 Dec 22.

PMID:
29271561
22.

Erratum for Alsultan et al., "Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis".

Alsultan A, Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Thiel B, Debanne SA, Boom WH, Diacon AH, Johnson JL, Peloquin CA.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e02229-17. doi: 10.1128/AAC.02229-17. Print 2018 Jan. No abstract available.

23.

Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study.

Jastaniah W, Alsultan A, Al Daama S, Ballourah W, Bayoumy M, Al-Anzi F, Al Shareef O, Abrar MB, Al Sudairy R, Al Ghemlas I.

Hematology. 2018 Jul;23(6):316-323. doi: 10.1080/10245332.2017.1412380. Epub 2017 Dec 7.

PMID:
29212418
24.

The association of duration of boarding in the emergency room and the outcome of patients admitted to the intensive care unit.

Al-Qahtani S, Alsultan A, Haddad S, Alsaawi A, Alshehri M, Alsolamy S, Felebaman A, Tamim HM, Aljerian N, Al-Dawood A, Arabi Y.

BMC Emerg Med. 2017 Nov 9;17(1):34. doi: 10.1186/s12873-017-0143-4.

25.

A phased SNP-based classification of sickle cell anemia HBB haplotypes.

Shaikho EM, Farrell JJ, Alsultan A, Qutub H, Al-Ali AK, Figueiredo MS, Chui DHK, Farrer LA, Murphy GJ, Mostoslavsky G, Sebastiani P, Steinberg MH.

BMC Genomics. 2017 Aug 11;18(1):608. doi: 10.1186/s12864-017-4013-y.

26.

Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis.

Alsultan A, Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Thiel B, Debanne SA, Boom WH, Diacon AH, Johnson JL, Peloquin CA.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01066-17. doi: 10.1128/AAC.01066-17. Print 2017 Oct. Erratum in: Antimicrob Agents Chemother. 2017 Dec 21;62(1):.

27.

Genetic determinants of HbF in Saudi Arabian and African Benin haplotype sickle cell anemia.

Shaikho EM, Farrell JJ, Alsultan A, Sebastiani P, Steinberg MH.

Am J Hematol. 2017 Sep;92(9):E555-E557. doi: 10.1002/ajh.24822. Epub 2017 Jul 19. No abstract available.

28.

Treatment results in children with myeloid leukemia of Down syndrome in Saudi Arabia: A multicenter SAPHOS leukemia group study.

Jastaniah W, Alsultan A, Al Daama S, Ballourah W, Bayoumy M, Al-Anzi F, Al Shareef O, Abrar MB, Al Sudairy R, Al Ghemlas I.

Leuk Res. 2017 Jul;58:48-54. doi: 10.1016/j.leukres.2017.04.004. Epub 2017 Apr 12.

PMID:
28445808
29.

Population Pharmacokinetics of Pyrazinamide in Patients with Tuberculosis.

Alsultan A, Savic R, Dooley KE, Weiner M, Whitworth W, Mac Kenzie WR, Peloquin CA; Tuberculosis Trials Consortium.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e02625-16. doi: 10.1128/AAC.02625-16. Print 2017 Jun.

30.

Phylogenetic characterization of circulating Dengue and Alkhumra Hemorrhagic Fever viruses in western Saudi Arabia and lack of evidence of Zika virus in the region: A retrospective study, 2010-2015.

Al-Saeed MS, El-Kafrawy SA, Farraj SA, Al-Subhi TL, Othman NA, Alsultan A, Ben Helaby HG, Alshawdari MM, Hassan AM, Charrel RN, Azhar EI, Hashem AM.

J Med Virol. 2017 Aug;89(8):1339-1346. doi: 10.1002/jmv.24785. Epub 2017 Mar 8.

PMID:
28198548
31.

Pharmacokinetics and pharmacodynamics of isoniazid in patients with intermediate resistance.

Alsultan A, Peloquin CA.

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):121-123. doi: 10.5588/ijtld.16.0689. No abstract available.

PMID:
28157477
32.

A Comprehensive, Ethnically Diverse Library of Sickle Cell Disease-Specific Induced Pluripotent Stem Cells.

Park S, Gianotti-Sommer A, Molina-Estevez FJ, Vanuytsel K, Skvir N, Leung A, Rozelle SS, Shaikho EM, Weir I, Jiang Z, Luo HY, Chui DHK, Figueiredo MS, Alsultan A, Al-Ali A, Sebastiani P, Steinberg MH, Mostoslavsky G, Murphy GJ.

Stem Cell Reports. 2017 Apr 11;8(4):1076-1085. doi: 10.1016/j.stemcr.2016.12.017. Epub 2017 Jan 19.

33.

Beyond Antibodies: Development of a Novel Protein Scaffold Based on Human Chaperonin 10.

Alsultan AM, Chin DY, Howard CB, de Bakker CJ, Jones ML, Mahler SM.

Sci Rep. 2016 Nov 22;5:37348. doi: 10.1038/srep37348.

34.

Hematopoietic stem cell transplantation in FANCJ/BRIP1 fanconi anemia.

Alsultan A, Essa M, Alsudairy R.

Bone Marrow Transplant. 2017 Mar;52(3):463-465. doi: 10.1038/bmt.2016.296. Epub 2016 Nov 21. No abstract available.

PMID:
27869810
35.

A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia.

Vathipadiekal V, Farrell JJ, Wang S, Edward HL, Shappell H, Al-Rubaish AM, Al-Muhanna F, Naserullah Z, Alsuliman A, Qutub HO, Simkin I, Farrer LA, Jiang Z, Luo HY, Huang S, Mostoslavsky G, Murphy GJ, Patra PK, Chui DH, Alsultan A, Al-Ali AK, Sebastiani P, Steinberg MH.

Am J Hematol. 2016 Nov;91(11):1118-1122. doi: 10.1002/ajh.24527. Epub 2016 Aug 22.

36.

ISONIAZID AND RIFAMPIN PHARMACOKINETICS IN TWO ASIAN ELEPHANTS (ELEPHAS MAXIMUS) INFECTED WITH MYCOBACTERIUM TUBERCULOSIS.

Egelund EF, Isaza R, Alsultan A, Peloquin CA.

J Zoo Wildl Med. 2016 Sep;47(3):868-871.

PMID:
27691967
37.

Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study.

Jastaniah W, Al Ghemlas I, Al Daama S, Ballourah W, Bayoumy M, Al-Anzi F, Al Shareef O, Alsultan A, Abrar MB, Al Sudairy R.

Leuk Res. 2016 Oct;49:66-72. doi: 10.1016/j.leukres.2016.08.009. Epub 2016 Aug 24.

PMID:
27580158
38.

Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis.

Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Peloquin CA, Alsultan A, Thiel BA, Debanne SM, Boom WH, Diacon AH, Johnson JL.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6591-6599. doi: 10.1128/AAC.01163-16. Print 2016 Nov.

39.

Demands and challenges for patients with sickle-cell disease requiring hematopoietic stem cell transplantation in Saudi Arabia.

Alsultan A, Jastaniah W, Al Afghani S, Al Bagshi MH, Nasserullah Z, Al-Suliman AM, Alabdulaali MK.

Pediatr Transplant. 2016 Sep;20(6):831-5. doi: 10.1111/petr.12767. Epub 2016 Jul 31.

PMID:
27477851
40.

A lethal phenotype associated with tissue plasminogen deficiency in humans.

Shamseldin HE, Aldeeri A, Babay Z, Alsultan A, Hashem M, Alkuraya FS.

Hum Genet. 2016 Oct;135(10):1209-11. doi: 10.1007/s00439-016-1711-5. Epub 2016 Jul 14.

PMID:
27417437
41.

Variants of ZBTB7A (LRF) and its β-globin gene cluster binding motifs in sickle cell anemia.

Shaikho EM, Habara AH, Alsultan A, Al-Rubaish AM, Al-Muhanna F, Naserullah Z, Alsuliman A, Qutub HO, Patra PK, Sebastiani P, Baltrusaitis K, Farrell JJ, Jiang Z, Luo HY, Chui DH, Al-Ali AK, Steinberg MH.

Blood Cells Mol Dis. 2016 Jul;59:49-51. doi: 10.1016/j.bcmd.2016.04.001. Epub 2016 Apr 13. No abstract available.

PMID:
27282567
42.

Homozygosity for a haplotype in the HBG2-OR51B4 region is exclusive to Arab-Indian haplotype sickle cell anemia.

Vathipadiekal V, Alsultan A, Baltrusaitis K, Farrell JJ, Al-Rubaish AM, Al-Muhanna F, Naserullah Z, Suliman A, Patra PK, Milton JN, Farrer LA, Chui DH, Al-Ali AK, Sebastiani P, Steinberg MH.

Am J Hematol. 2016 Jun;91(6):E308-11. doi: 10.1002/ajh.24368. Epub 2016 Apr 28. No abstract available.

43.

Activation-resistant homozygous protein C R229W mutation causing familial perinatal intracranial hemorrhage and delayed onset of thrombosis.

Alsultan A, Gale AJ, Kurban K, Khalifah M, Albadr FB, Griffin JH.

Thromb Res. 2016 Jul;143:17-21. doi: 10.1016/j.thromres.2016.04.011. Epub 2016 Apr 23.

44.

The genetics of amyotrophic lateral sclerosis: current insights.

Alsultan AA, Waller R, Heath PR, Kirby J.

Degener Neurol Neuromuscul Dis. 2016 May 13;6:49-64. doi: 10.2147/DNND.S84956. eCollection 2016. Review.

45.

Prevalence, knowledge and attitude of prohibited substances use (doping) among Saudi sport players.

Al Ghobain M, Konbaz MS, Almassad A, Alsultan A, Al Shubaili M, AlShabanh O.

Subst Abuse Treat Prev Policy. 2016 Apr 16;11:14. doi: 10.1186/s13011-016-0058-1.

46.

Clinical characteristics and genetic subtypes of Fanconi anemia in Saudi patients.

Ghazwani Y, AlBalwi M, Al-Abdulkareem I, Al-Dress M, Alharbi T, Alsudairy R, Alomari A, Aljamaan K, Essa M, Al-Zahrani M, Alsultan A.

Cancer Genet. 2016 Apr;209(4):171-6. doi: 10.1016/j.cancergen.2016.02.003. Epub 2016 Feb 15.

PMID:
26968956
47.

Optimizing the clinical pharmacology of tuberculosis medications.

Egelund EF, Alsultan A, Peloquin CA.

Clin Pharmacol Ther. 2015 Oct;98(4):387-93. doi: 10.1002/cpt.180. Epub 2015 Jul 22. Review.

PMID:
26138226
48.

Limited sampling strategy and target attainment analysis for levofloxacin in patients with tuberculosis.

Alsultan A, An G, Peloquin CA.

Antimicrob Agents Chemother. 2015 Jul;59(7):3800-7. doi: 10.1128/AAC.00341-15. Epub 2015 Apr 13.

49.

BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.

Sebastiani P, Farrell JJ, Alsultan A, Wang S, Edward HL, Shappell H, Bae H, Milton JN, Baldwin CT, Al-Rubaish AM, Naserullah Z, Al-Muhanna F, Alsuliman A, Patra PK, Farrer LA, Ngo D, Vathipadiekal V, Chui DH, Al-Ali AK, Steinberg MH.

Blood Cells Mol Dis. 2015 Mar;54(3):224-30. doi: 10.1016/j.bcmd.2015.01.001. Epub 2015 Jan 30.

50.

High-dose Chemotherapy With Autologous Stem Cell Rescue in Saudi Children Less Than 3 Years of Age With Embryonal Brain Tumors.

Alsultan A, Alharbi M, Al-Dandan S, Bayoumi Y, Alharbi T, Alsudairy R, Alomari A, Aljamaan K, Musleh O, Alharbi Q, Jarrar M.

J Pediatr Hematol Oncol. 2015 Apr;37(3):204-8. doi: 10.1097/MPH.0000000000000301.

PMID:
25551668

Supplemental Content

Loading ...
Support Center